Regencell Bioscience (RGC) has had the highest return this year by a US stock in the Nasdaq Composite (IXIC), returning 10,888%.

Regencell Bioscience (RGC) has had the highest return this year by a US stock in the Nasdaq Composite (IXIC), returning 10,888%.
ASSET | YEAR | % RETURN |
---|---|---|
Regencell Bioscience (RGC) | 2025 | 10,888.02% |
DeFi Development (DFDV) | 2025 | 3,540.96% |
WW International, Inc Common Stock (WW) | 2025 | 2,724.43% |
Diginex Limited Ordinary Shares (DGNX) | 2025 | 1,355.4% |
Asset Entities Inc Class B Common Stock (ASST) | 2025 | 1,140% |
SRM Entertainment, Inc Common Stock (SRM) | 2025 | 1,059.03% |
Oncology Institute (TOI) | 2025 | 949.02% |
Global Interactive Technologies (GITS) | 2025 | 900% |
Kindly (NAKA) | 2025 | 875% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 2025 | 806.08% |
Abits (ABTS) | 2025 | 747.18% |
Sonnet Biotherapeutics (SONN) | 2025 | 560.27% |
TMC the metals (TMC) | 2025 | 538.6% |
ABVC BioPharma (ABVC) | 2025 | 494.92% |
Mink Therapeutics (INKT) | 2025 | 480.14% |
mF International Limited Ordinary Shares (MFI) | 2025 | 471.85% |
Dominari (DOMH) | 2025 | 468.12% |
Quantum BioPharma (QNTM) | 2025 | 453.16% |
Aeva Technologies, Inc Common Stock (AEVA) | 2025 | 450.82% |
So-Young International (SY) | 2025 | 441.44% |
Oriental Culture Holding (OCG) | 2025 | 402.61% |
Pheton Holdings Ltd Class A Ordinary Shares (PTHL) | 2025 | 399.3% |
ThredUp (TDUP) | 2025 | 394.44% |
Immunoprecise Antibodies (IPA) | 2025 | 382.93% |
Vigil Neuroscience (VIGL) | 2025 | 374.71% |